Vitalhub Corp. (TSE:VHI) Given Average Recommendation of “Buy” by Brokerages

Vitalhub Corp. (TSE:VHI) has earned an average rating of “Buy” from the six research firms that are currently covering the company, MarketBeat.com reports. Five equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month target price among analysts that have covered the stock in the last year is C$12.67.

Separately, National Bank Financial decreased their price objective on Vitalhub from C$14.00 to C$11.00 and set an “outperform” rating for the company in a report on Wednesday, May 27th.

Vitalhub Trading Down 1.3%

TSE:VHI opened at C$7.73 on Friday. The stock has a market capitalization of C$489.00 million, a price-to-earnings ratio of 64.42, a PEG ratio of 1.18 and a beta of 0.91. The firm has a fifty day simple moving average of C$7.19 and a two-hundred day simple moving average of C$7.52. Vitalhub has a 12 month low of C$6.46 and a 12 month high of C$13.81.

Vitalhub (TSE:VHI) last announced its quarterly earnings data on Thursday, August 6th. The company reported C$0.03 earnings per share for the quarter. Vitalhub had a net margin of 5.89% and a return on equity of 2.79%. The firm had revenue of C$31.74 million for the quarter. Equities analysts predict that Vitalhub will post 0.2296467 earnings per share for the current fiscal year.

Vitalhub Company Profile

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.